Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Interest & Investment Income (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Interest & Investment Income for 3 consecutive years, with $120384.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income rose 1414.26% year-over-year to $120384.0, compared with a TTM value of $181259.0 through Sep 2025, up 108.08%, and an annual FY2024 reading of $19943.0, down 77.01% over the prior year.
  • Interest & Investment Income was $120384.0 for Q3 2025 at SBC Medical Group Holdings, up from $22882.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.3 million in Q1 2023 and bottomed at -$2.3 million in Q4 2023.
  • Average Interest & Investment Income over 3 years is $4480.0, with a median of $17689.0 recorded in 2024.
  • The sharpest move saw Interest & Investment Income plummeted 98.61% in 2024, then surged 1414.26% in 2025.
  • Year by year, Interest & Investment Income stood at -$2.3 million in 2023, then soared by 99.24% to -$17340.0 in 2024, then soared by 794.26% to $120384.0 in 2025.
  • Business Quant data shows Interest & Investment Income for SBC at $120384.0 in Q3 2025, $22882.0 in Q2 2025, and $55333.0 in Q1 2025.